| Literature DB >> 35433716 |
Huidan Zhao1,2, Xianlan Zhao1,2, Chen Chen1,2, Ya Tao1,2, Ruixia Guo1.
Abstract
Background: The distinguished Triple-P procedure has been reported as a conservative surgical alternative to peripartum hysterectomy for placental accreta spectrum (PAS). In this study, we modified the procedure combined with prophylactic abdominal aorta balloon occlusion and/or tourniquet and evaluated the effect and long-term outcomes.Entities:
Keywords: Triple-P procedure; abdominal aorta; balloon occlusion; conservative treatment/methods; peripartum hysterectomy; placenta accreta spectrum (PAS)
Year: 2022 PMID: 35433716 PMCID: PMC9005881 DOI: 10.3389/fmed.2022.839716
Source DB: PubMed Journal: Front Med (Lausanne) ISSN: 2296-858X
Figure 1Ultrasonograms of the participant. (A) Increased placental thickness under preoperative ultrasound examination; (B) Loss of hypoechoic retroplacental zone and numerous large and irregular lacunae in the placenta; (C) Absence of the lower muscle layer of uterus and Vessels with high velocity blood flow leading from the myometrium into the placental lacunae; (D) Striking amount of color Doppler signal seen between the myometrium and the posterior wall of the bladder.
Figure 2MRI images of the participant. (A) MRI coronal plane on T2-weighted images, showing thickened placenta, heterogeneous signal intensity; (B) MRI sagittal plane, showing unclear boundary of placenta and uterine wall; (C) MRI cross section, showing focal interruption of myometrium.
Figure 3Image of the balloon. The balloon was placed into the distal abdominal aorta beneath the opening of the renal arteries.
Figure 4Process of the procedure. (A) The uterine incision was over the upper border of the placenta. (B) A tourniquet was put as low as possible at the lower segment of the uterus. The bladder was pushed down and the anterior myometrium was partially resected with the placenta unseparated. (C) A single continuous suture was made along the lower lip of the uterine incision. (D) The lower transverse incision at the uterine was sutured in one layer. This area was still permeated with tortuous vessels (the arrow).
Comparation of demographic characteristics of the patients with placenta increta/percreta in two groups.
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|
| Modified Triple-P | 142 | 32.6 ± 4.4 | 4 (3–5) | 1 (1–2) | 35 (34.1–35.9) | 10.5 (9.0–12.0) | 6 (4.2) |
| Control | 194 | 32.0 ± 5.0 | 4 (3–5) | 1 (1–2) | 35 (33.4–35.8) | 11.0 (9.8–12.0) | 5 (2.6) |
| Statistic value | 1.06 | 1.08 | 0.72 | 0.66 | 0.26 | 0.70 | |
| 0.292 | 0.19 | 0.47 | 0.51 | 0.79 | 0.40 |
PAS score refers to the scoring system designed by Peking University Third Hospital.
Comparation of perioperative data of the patients with placenta increta/percreta treated by two different procedures.
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
| Modified Triple-P | 28,486 ± 8,574 | 108 (76.1) | 104 (73.2) | 99.5 (84.0–120.0) | 1,200 (687–1,812) | 400 (0–800) | 415 (332–655) | 4 (4–7) | 2,652 ± 614 |
| Control | 32,384 ± 11,689 | 138 (71.1) | 136 (70.1) | 109.0 (83.8–143.0) | 1,300 (800–2,500) | 800 (0–1,200) | 555 (267–785) | 5 (4–7) | 2,671 ± 649 |
| Statistic value | 3.37 | 1.01 | 0.40 | 2.09 | 2.06 | 1.41 | 1.60 | 3.31 | 0.26 |
| 0.001 | 0.31 | 0.53 | 0.04 | 0.04 | 0.16 | 0.11 | 0.01 | 0.80 |
P < 0.05. PABO, abdominal aorta balloon occlusion; CRBC, concentrated red blood cells.
Comparation of postoperative follow-up data of the patients with placenta increta/percreta treated by two different procedures.
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
| Modified Triple-P | 2 (1.4) | 12 (8.5) | 4 (2.8) | 4 (2.8) | 3 (2.1) | 0 (0) | 2 (1.4) |
| Control | 4 (2.1) | 19 (9.9) | 3 (1.2) | 6 (3.1) | 4 (2.1) | 1 (0.5) | 4 (2.1) |
| Statistic value | 0.20 | 0.18 | 0.65 | 0.02 | 0.01 | 0.73 | 0.20 |
| 0.62 | 0.67 | 0.42 | 0.88 | 0.97 | 0.39 | 0.62 |
UAE, uterine artery embolism.
Comparation of long-term follow-up data of the patients with placenta increta/percreta treated by two different procedures.
|
|
|
|
|
|
|---|---|---|---|---|
| Long-term follow-up | 0.15 | 0.69 | ||
| Succeeded | 127 (89.4) | 176 (90.7) | ||
| Lost | 15 (10.6) | 18 (9.3) | ||
| Time after the procedure | ||||
| More than 2 years | 49 (34.5) | 63 (32.5) | 0.15 | 0.69 |
| More than 1 year | 113 (79.6) | 148 (76.3) | 0.51 | 0.48 |
| More than 6 months | 127 (89.4) | 176 (90.7) | 0.15 | 0.69 |
| Breast feeding situation | 0.29 | 0.59 | ||
| Artificial feeding | 14 (11.0) | 23 (13.1) | ||
| Breast feeding | 113 (89.0) | 153 (86.9) | ||
| Menstruation restored | 0.34 | 0.56 | ||
| Yes | 121 (95.3) | 170 (96.6) | ||
| No | 6 (4.7) | 6 (3.4) | ||
| Time of menstruation resumed | 0.79 | 0.67 | ||
| <5 months | 67 (52.8) | 98 (55.7) | ||
| 5–10 months | 42 (33.1) | 50 (28.4) | ||
| >10 months | 18 (14.1) | 28 (15.9) | . | |
| Menstrual quantity | 0.67 | 0.71 | ||
| Increase | 5 (4.1) | 6 (3.5) | ||
| Same | 104 (86.0) | 142 (83.5) | ||
| Decrease | 12 (9.9) | 22 (12.9) | ||
| Menstrual period (days) | 0.16 | 0.93 | ||
| Longer | 8 (6.6) | 12 (7.0) | ||
| Same | 109 (90.1) | 151 (88.8) | ||
| Shorter | 4 (2.7) | 7 (4.1) | ||
| Intrauterine adhesion | 1 (0.8) | 1 (0.6) | 0.05 | 0.82 |
| Light chronic pain of abdomen | 5 (3.9) | 4 (2.3) | 0.71 | 0.40 |
| Lower extremity discomfort | 3 (2.4) | 6 (3.4) | 0.28 | 0.60 |